Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.
Today, National Traders Association announced new research reports highlighting Bruker Corporation (NASDAQ: BRKR), Agilent Technologies Inc. (NYSE: A), General Electric Company (NYSE: GE), Becton, Dickinson and Co. (NYSE: BDX) and Thermo Fisher Scientific Inc. (NYSE: TMO).
Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Bruker Corporation Research Report Bruker shares are up after the company announced that its revenue for the fourth quarter grew 8.9 percent to $517.3 million. The company highlights the launch of 30 new products, including several breakthrough innovations and improved margins. Analysts have a positive outlook for the company for the next quarter, as the X-ray maker is expected to report revenue growth along with higher profits and stronger cash flow. It may also benefit from its acquisitions in the coming year, including SkyScan NV, a medical device company in Belgium, which makes micro-computed tomography (CT) systems for 3D X-ray systems. For 2013, management expects year-over-year revenue growth of 4 to 5 percent and non-GAAP EPS growth of 6 to 10 percent.
While The Full Research Report on Bruker Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.NationalTradersAssociation.org/r/full_research_report/92b7_BRKR -- Agilent Technologies Inc. Research Report Agilent Technologies reported net revenue growth of 3 percent to $1.68 billion along with an increased number of orders by 5 percent to $1.71 billion. Agilent CEO Bill Sullivan comments that he is excited about Agilent's long-term prospects, including opportunities in emerging markets. The company will continue to invest in R&D to ensure the production of cutting-edge products in order to increase profitability and drive growth. It recently unveiled its increasing range of mobile measurement tools to enable rapid onsite screening and analysis of energy, environmental, food, forensics and materials markets. One of its subsidiaries, Dako, also received FDA approval for its IQISH product, which reduces turnaround time for cancer evaluation from two days to three and a half hours. According to analysts, the company's broader portfolio and shift in focus to life sciences, genomics, diagnostics and wireless test markets are making the company's growth potential encouraging. The Full Research Report on Agilent Technologies Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.NationalTradersAssociation.org/r/full_research_report/76f0_A -- General Electric Company Research Report GE rallied by almost 2 percent after it announced that it would invest more than $300 million in Indonesian health care, deep-sea drilling, and forming relationships with local companies to expand into the emerging market. Recently, GE Healthcare announced an expanded partnership with ServiceSource to include the Japanese market. With this, the company now works in 11 countries in the Asia-Pacific.
Furthermore, GE also announced the first global commercial installation of its Optima NM/CT 640 technology, which will help physicians focus on key needs in diagnostic imaging, including high-quality visuals, low radiation dose and short exam times for patients. The company hit a new 52-week high following the news, and analysts have been praising company for its recent moves. The Full Research Report on General Electric Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.NationalTradersAssociation.org/r/full_research_report/9786_GE -- Becton, Dickinson and Co. Research Report Becton Dickinson reported earnings that climbed 138 percent boosted by flu vaccine sales. Supplies made by the company include the syringes and needles used in the flu vaccine and a product that helps doctors diagnose the flu. The company also stated that it sees continued strength in emerging markets, with China sales rising by more than 24 percent. Becton Dickinson raised its guidance following these results.
Analysts are also bullish about the stock, citing its diverse portfolio and strong growth potential in the global market. The Full Research Report on Becton, Dickinson and Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.NationalTradersAssociation.org/r/full_research_report/9980_BDX -- Thermo Fisher Scientific Inc. Research Report Thermo Fisher reported adjusted EPS in the fourth quarter of 2012, 14 percent higher than the prior year quarter, while the full year grew 19 percent to a record $4.94. ThermoFischer expanded its high content analysis portfolio with three new products that are designed to quickly generate data about cells, speeding up cell research. Its new products include the Thermo Scientific ArrayScan XTI High Content Analysis (HCA) Reader, the Thermo Scientific CellInsight NXT High Conttent Screening (HCS) Platform, and the Thermo Scientific X1 upgrade for current ArrayScan VTI customers. With continued investments in innovation, commercial excellence and emerging markets, the company is expected to deliver another successful year. Full Research Report on Thermo Fisher Scientific Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.NationalTradersAssociation.org/r/full_research_report/5fa4_TMO -- Consider National Traders Association Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop - long before they become the next top news on major financial networks.